Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Iowa for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Iowa only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Iowa (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Bharat Jenigiri (NPI 1912053364)

Field	Value
Entity Type	Individual
Organization	Bharat Jenigiri
Address	202 10th Street Se
City	Cedar Rapids
State	IA
ZIP	52403
Taxonomy	Medical Oncology Physician
NPI Enumerated	January 26, 2007

Payer Source	Total Paid
Medicare	$1.5M
Medicaid	$0

Key Findings

This provider is a medical oncology physician primarily operating in an infusion- and imaging-driven practice: the single largest revenue code is J9271 (pembrolizumab) which accounts for $808.4K and is the dominant biller, supported by additional chemotherapy administration codes such as 96413 and 96401 and supportive/adjunct drugs like J2506 (pegfilgrastim) and J0897 (denosumab). The code mix (high-volume monoclonal antibody, chemo administration, growth factor support, and oncology imaging 78815/A9596) aligns with an oncology practice that provides both systemic therapy and diagnostic imaging coordination.

Revenue is highly concentrated in a small set of Medicare codes: the precomputed top-3 Medicare codes by revenue account for 71.1% of the provider's total Medicare revenue, indicating the practice derives most of its Medicare income from a few high-cost oncology drugs and related services rather than a broad mix of low-revenue codes. This concentration suggests financial sensitivity to utilization or pricing changes for those leading codes.

On payer mix the provider is effectively single-payer at the claim level: lifetime Medicare revenue is $1.5M while there is no Medicaid billing on file. This provider’s commercial or other non-Medicare revenue is not shown, but for public programs the operation is essentially Medicare-dependent based on available data.

Competitive standing for the largest revenue driver is modest nationally: J9271 activity ($808.4K; 18.8K claims) ranks #461 of 1841 providers nationally (74th percentile), which the data labels as typical or unremarkable volume relative to peers. Several E/M codes (99214 and 99215) are notable exceptions where the provider shows above-typical national volumes—99214 ranks in the 96th percentile and 99215 in the 97th—indicating relatively higher ambulatory evaluation intensity compared with the average national clinician mix.

Other high-cost diagnostic and imaging items show mixed competitiveness: 78815 (PET/CT) produced $157.5K (145 claims) and ranks in the 78th percentile nationally, and A9596 (gallium imaging) produced $75.8K and ranks near the middle of peers at the 41st percentile. These ranks indicate the provider uses advanced oncologic imaging at an above-typical but not dominant level, consistent with active staging and treatment monitoring in a medical oncology setting.

Several supportive-care and laboratory codes show high relative volumes for routine oncology management: lab panels (80053), CBC (85025), ferritin (82728), iron studies (83550), and specimen collection (36415) all appear among the top codes and many rank at or above the 90th percentile nationally for those CPTs. This pattern reflects ongoing chronic monitoring typical of systemic oncology therapy and survivorship care.

Tenure in the Medicare program is long: the provider’s NPI was enumerated on 2007-01-26 (~19 years ago), indicating sustained presence and experience in the Medicare marketplace that may support established referral relationships and steady patient volume.

Statistical outliers are limited but meaningful: most high-revenue drug and infusion codes are characterized as "typical, unremarkable volume," while key evaluation-and-management codes (99214 and 99215) are labeled "notably above typical national volume," signaling that this clinician documents and bills a higher intensity of outpatient visits than most peers. Those above-typical E/M volumes could reflect a sicker Medicare panel, longer visit times, or practice coding patterns focused on higher-complexity visits.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

69 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J9271	Injection, pembrolizumab, 1 mg	18,800	$40	$808.4K
78815	PET and CT scans are both standard imaging tools that allow doctors to evaluate the location and metabolic actions of tumors or cancer inside the body before beginning an active treatment regimen.…	150	$1,090	$157.5K
J0897	Injection, denosumab, 1 mg	5,160	$20	$92.9K
A9596	Gallium ga-68 gozetotide, diagnostic, (illuccix), 1 millicurie	90	$820	$75.8K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	800	$90	$72.7K
99215	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the…	330	$130	$43.8K
J1439	Injection, ferric carboxymaltose, 1 mg	36,750	$1	$36.8K
96413	Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…	370	$90	$34.5K
J2506	Injection, pegfilgrastim, excludes biosimilar, 0.5 mg	290	$80	$23K
99213	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the…	350	$60	$20.8K

Showing 1–10 of 69

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 69 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Iowa Distribution

Bharat Jenigiri — 7 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Iowa

Full comparison — all codes billed, vs. state median

69 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J9271	11	30	17,200	$40	$902.3K
J0897	38	190	1,920	$20	$74.1K
A9596	3	10	80	$790	$70.7K
J1439	9	10	41,250	$1	$39.7K
J2506	12	20	440	$80	$38.9K
96413	21	80	210	$90	$24K
78815	13	90	40	$270	$20.4K
J0185	6	20	6,890	$1	$14.5K
99214	166	4,690	100	$70	$14.4K
74177	176	210	130	$80	$12.5K

Showing 1–10 of 69

Related Providers

Other providers that share a Tax Identification Number (TIN) with Bharat Jenigiri, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Physicians' Clinic Of Iowa, PC	IA	Surgery Physician	$0	$4.9M
Bogdan Cherascu	IA	Rheumatology Physician	$2.4M	$0
Vijay Aluri	IA	Rheumatology Physician	$2M	$0
William Fusselman	IA	Hematology & Oncology Physician	$1.3M	$0
Rasa Buntinas	IA	Hematology & Oncology Physician	$1.1M	$0
Ritu Munjal	IA	Family Medicine Physician	$1M	$0
Harinder Singh	IA	Rheumatology Physician	$789.3K	$0
Jonathan Rippentrop	IA	Urology Physician	$487.4K	$0
Thomas Richardson	IA	Urology Physician	$373K	$0
Sandeep Munjal	IA	Adult Reconstructive Orthopaedic Surgery Physician	$322K	$0

Nearby Providers

Other providers in the same ZIP code as Bharat Jenigiri, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Mercy Medical Center	IA	General Acute Care Hospital	$0	$26.4M
Eastern Iowa Health Center	IA	Family Medicine Physician	$0	$24.5M
Eastern Iowa Health Center	IA	Family Medicine Physician	$0	$18.5M
Eastern Iowa Health Center	IA	General Practice Dentistry	$0	$14.4M
Linn County Emergency Medicine PC	IA	Emergency Medicine Physician	$0	$9.8M
C R Iv Service Inc	IA	Home Infusion Therapy Pharmacy	$0	$5.8M
Mercy Medical Center	IA	Cardiovascular Disease Physician	$0	$5.1M
C R Pharmacy Service Inc	IA	Oxygen Equipment & Supplies (DME)	$0	$2.4M
Eastern Iowa Sleep Center, LLC	IA	Sleep Disorder Diagnostic Clinic/Center	$243.7K	$1.6M
Rapids Dental	IA	Dental Clinic/Center	$0	$1.7M

Bharat Jenigiri — Billing Profile & Reimbursement Data

Sign up for Bharat Jenigiri — Billing Profile & Reimbursement Data policy alerts

Bharat Jenigiri — Billing Profile & Reimbursement Data

Sign up for Bharat Jenigiri — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References